Proteins are the molecular machines of all living cells and have been exploited for use in many applications, including therapeutics and industrial catalysts. To overcome the limitations of naturally occurring proteins, protein engineering is used to improve protein characteristics such as stability and functionality. In a new study, researchers demonstrate a machine learning algorithm that […]
Home »
A protein found to be effective at reversing aging in skeletal muscle cells
A University at Buffalo-led research team has shown that a protein named for the mythical land of youth in Irish folklore is effective at reversing aging in skeletal muscle cells. Published Sept. 3 in Science Advances, the study centers on the protein NANOG, which is derived from Tír na nÓg, a place in Irish lore […]
Protein tenascin-C important in retinal blood flow disorders
Many eye diseases are associated with a restricted blood supply, known as ischaemia, which can lead to blindness. The role of the protein tenascin-C, an extracellular matrix component, in retinal ischaemia was investigated in mice by researchers from Ruhr-Universität Bochum (RUB). They showed that tenascin-C plays a crucial role in damaging the cells responsible for […]
Protein linked to sex differences in age-related dopamine neuron loss
It is not every day that scientists come across a phenomenon so fundamental that it is observed across fruit flies, rodents and humans. In a paper published today in Aging Cell, neuroscientists from the University of Pittsburgh Schools of the Health Sciences discovered that a single protein—a glutamate transporter on the membrane of vesicles that […]
Characterization of lab-produced neutralizing antibodies targeting SARS-CoV-2
A new study led by Hans-Martin Jäck of the Friedrich-Alexander University Erlangen-Nuremberg in Germany engineered clusters of neutralizing monoclonal antibodies using a transgenic mouse model. A unique characteristic for the antibodies was the different ways it bound to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the overall reduction in the viral spread for […]
Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?
When a virus invades an individual, both innate and adaptive immunity play crucial roles. The successful viral pathogens can antagonize these immune pathways with genes that inhibit the key players in the immune system. The coronavirus disease 2019 (COVID-19) pandemic is caused by the novel beta coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It […]
More new SARS-CoV-2 variants are highly likely
In a recent report posted to the bioRxiv* preprint server, researchers from the United Kingdom and Uganda reveal unique protein features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relative to other representatives of Sarbecoviruses. The causative agent of the coronavirus disease 2019 (COVID-19), SARS-CoV-2, belongs to the Betacoronavirus genus and Sarbecovirus subgenus of the […]
Study indicates an amyloid link between melanoma and Parkinson’s disease
On the surface, Parkinson's disease -; a neurodegenerative disorder -; and melanoma -; a type of skin cancer -; do not appear to have much in common. However, for nearly 50 years, doctors have recognized that Parkinson's disease patients are more likely to develop melanoma than the general population. Now, scientists report a molecular link […]
Inflammation-fighting protein could improve treatment of rheumatoid arthritis
New research led by scientists at Washington State University has found that a protein known as GBP5 appears to play a key role in suppressing inflammation in rheumatoid arthritis, a potentially debilitating disease in which the immune system mistakenly attacks the body’s own joint tissues. Published in the journal Arthritis & Rheumatology, the discovery could […]
IONTAS identifies novel SARS-CoV-2 neutralising antibodies
IONTAS Limited (IONTAS) and FairJourney Biologics S.A (FJB)., leaders in the discovery and optimization of fully human antibodies, have announced the identification of neutralizing antibodies, which bind to multiple emerging SARS-CoV-2 variants. The results, generated from a combination of phage display technology and B-cell receptor repertoire sequencing of hospitalized COVID-19 patients, have identified potent neutralizing […]